Breast health leader will highlight expanding portfolio for breast
MARLBOROUGH, Mass.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/ASBS?src=hash” target=”_blank”gt;#ASBSlt;/agt;–Hologic, Inc. (Nasdaq: HOLX) will showcase its growing breast surgery
franchise, which includes products such as the new Trident® HD specimen
radiography system, LOCalizer™ wire-free guidance system and
the BioZorb® marker, in Booth #103 at the 20th
Annual Meeting of The American Society of Breast Surgeons (ASBS) in
Dallas from April 30 to May 5.
The pioneer behind the Genius™ 3D Mammography™
exam, Hologic has recently expanded its product portfolio significantly
through insight-driven innovation and strategic acquisitions to address
the entire clinical continuum of breast cancer diagnosis and care. From
digital specimen radiography and stereotactic breast biopsy systems, to
breast biopsy markers and surgical guidance systems – Hologic’s
comprehensive suite of products is designed to meet the unmet and
changing needs of radiologists, pathologists and breast surgeons.
“ASBS marks an exciting milestone this year as we debut our newly
expanded portfolio of breast conserving surgery solutions,” said Pete
Valenti, Hologic’s Division President, Breast and Skeletal Health
Solutions. “We look forward to building upon our relationships with this
community of leading breast surgeons and showcasing our growing suite of
products designed to improve cancer detection, patient satisfaction and
comfort, and facility workflow.”
A sampling of the products on display in the Hologic booth includes:
HD specimen radiography system, a next-generation solution
that delivers enhanced image quality, improved workflow and instant
sample verification during breast-conserving surgeries and
stereotactic breast biopsies.1 The system, which recently
received FDA clearance in the U.S. and a CE Mark in Europe, uses
amorphous selenium direct capture imaging – the same detector
technology used in Hologic’s 3Dimensions™ mammography system – to
generate crisp, clear, high-resolution images. The system also
features a bigger detector that allows for complete imaging of larger
breast surgical specimens, along with a wide range of surgical and
wire-free guidance system, which is designed to enable
precision and ease of use for breast surgery guidance. The LOCalizer
tag is designed to replace traditional wire-guided methods, helping
provide increased comfort and convenience for patients and their
healthcare teams. Additionally, the Tag is designed to be implanted
into the breast any time prior to the surgery, providing increased
flexibility for patients and providers. A recent study has shown that
the LOCalizer tag may be able to reduce positive margin rates with
lumpectomy due to the unique feature of reading distance from the tag.3
3D bioabsorbable marker, an implantable three-dimensional
marker that potentially enables a more targeted radiation therapy and
helps clinicians overcome challenges in breast conserving surgery or
lumpectomy. When used to mark the surgical site, BioZorb has been
shown to yield good to excellent cosmetic outcomes for at least two
years post-surgery and result in minimal scarring on mammography after
breast conserving surgery.4,5 Additionally, the marker has
been shown to improve accuracy in setup and boost targeting as
reported by 96 percent of radiation oncologists.6
wireless gamma probe, a sterile, single-use device for common,
radio-guided surgical procedures that senses hotspots using an
innovative detector and heuristic audio feedback technology. The
TruNode probe is designed to perform less invasively, and may reduce
infection risk from reprocessing due to its sterile, single-use
Hologic will also host a breakfast symposium, BioZorb® and a New Way
to 5-day radiation, featuring Cary Kaufman, MD, FACS and Valerie
Gorman, MD, FACS on Saturday, May 4 from 6:30 – 7:45am. Additional hands-on
workshops hosted by Hologic will cover topics such as stereotactic
breast biopsy, oncoplastic skills and portable breast ultrasound.
The Genius™ 3D Mammography™ exam (also known as
the Genius™ exam) is only available on a Hologic®3D
Mammography™system. It consists of a 2D and 3D™ image
set, where the 2D image can be either an acquired 2D image or a 2D image
generated from the 3D™ image set. There are more than 6,000
Hologic 3D Mammography™ systems in use in the U.S. alone, so
women have convenient access to the Genius exam. To learn more about the
Genius exam, visit http://www.Genius3DNearMe.com.
About Hologic, Inc.
Hologic, Inc. is an innovative medical technology company primarily
focused on improving women’s health and well-being through early
detection and treatment. For more information on Hologic, visit www.hologic.com.
Hologic, 3D, 3D Mammography, 3Dimensions, BioZorb, Genius, The Science
of Sure, Trident and TruNode are trademarks and/or registered trademarks
of Hologic, Inc., and/or its subsidiaries in the United States and/or
other countries. Hologic is an exclusive distributor and licensee of the
LOCalizer product and trademark, which is manufactured by Health Beacons.
This news release may contain forward-looking information that involves
risks and uncertainties, including statements about the use of Hologic
products. There can be no assurance these products will achieve the
benefits described herein or that such benefits will be replicated in
any particular manner with respect to an individual patient, as the
actual effect of the use of the products can only be determined on a
case-by-case basis. In addition, there can be no assurance that these
products will be commercially successful or achieve any expected level
of sales. Hologic expressly disclaims any obligation or undertaking to
release publicly any updates or revisions to any such statements
presented herein to reflect any change in expectations or any change in
events, conditions or circumstances on which any such data or statements
This information is not intended as a product solicitation or promotion
where such activities are prohibited. For specific information on what
products are available for sale in a particular country, please contact
a local Hologic sales representative or write to [email protected].
SOURCE: Hologic, Inc.
1 Wilson A. Trident 2.0 QUAL Qualitative Findings. Explore
and identify the ideal breast biopsy verification system from the OR.
Kadence International. July 2016.
2 Compared to original
3 N = 50 patient, single arm pilot study.
DiNome M et al. Microchipping the breast: an effective new technology
for localizing non-palpable breast lesions for surgery. Poster
presentation, Society of Surgical Oncology annual meeting, Mar 27-30,
4 Kaufman, et al. Oncoplastic
Surgery with the 3-D Tissue Implant Maintains Post-Lumpectomy Breast
Contour. Poster presented at the American Society of Breast Surgeons
18th Annual Meeting, May 2-5, 2018.
5 Kaufman CS, et al. Registry
Study of 337 Bio-Absorbable 3-D Implants Marking Lumpectomy Cavity
Benefit Cosmesis While Targeting Radiation. Poster presented at the
Society of Surgical Oncology Annual Cancer Conference March 15-17, 2017.
Harms S, et al. Mammographic
imaging after partial breast reconstruction: Impact of a bioabsorbable
breast implant. J Clin Oncol 33, 2015 (suppl 28S; abstr 111)